Contemporary OB/GYN

12/22/2025

A study found higher postpartum hemorrhage rates when objective blood loss measures were used, suggesting subjective estimates often underestimate prevalence.

Read more: https://www.contemporaryobgyn.net/view/objective-blood-loss-measures-reveal-higher-postpartum-hemorrhage-rates

12/22/2025

A large systematic review found standardized second-trimester ultrasound screening for vasa previa detects nearly all cases and is linked to high perinatal survival.

Read more: https://www.contemporaryobgyn.net/view/routine-second-trimester-ultrasound-screening-accurately-identifies-vasa-previa

12/22/2025

A study found women ≥65 years have higher odds of late-stage vs younger women, despite guidelines allowing screening cessation after adequate prior screening.

Read more: https://www.contemporaryobgyn.net/view/late-stage-cervical-cancer-risk-higher-in-older-women

12/19/2025

A new meta-analysis found transabdominal cervical was associated with lower perinatal mortality and rates vs transvaginal cerclage, with low overall certainty of evidence.

Read more: https://www.contemporaryobgyn.net/view/transabdominal-cerclage-linked-to-lower-preterm-birth-vs-transvaginal-cerclage

12/19/2025

A study found is significantly more common in adolescents with heavy , affecting over half of those with the condition compared with about one-quarter without it.

Read more: https://www.contemporaryobgyn.net/view/heavy-menstrual-bleeding-linked-to-iron-deficiency-in-adolescents

12/19/2025

New data may reshape cUTI treatment options.

GSK and Spero Therapeutics has resubmitted its NDA for tebipenem HBr, an investigational oral carbapenem antibiotic for complicated urinary tract infections. Phase 3 data presented at IDWeek showed efficacy comparable to IV imipenem-cilastatin.

Here’s what clinicians should know about the trial results and regulatory update:
https://hubs.li/Q03YKcS40

12/18/2025

In a 12-week trial, HMI-115 showed dose-dependent reductions in dysmenorrhea and non-menstrual pelvic pain compared with placebo, addressing an unmet need for nonhormonal pain treatments.

Read more: https://www.contemporaryobgyn.net/view/hmi-115-shows-promising-pain-relief-in-endometriosis-patients

12/18/2025

The FDA has granted 510(k) clearance to the FemVue Controlled device for assessing fallopian tube status. The device combines FemVue and FemChec technologies and uses alternating saline and air contrast during .

Read more: https://www.contemporaryobgyn.net/view/fda-clears-femvue-controlled-for-in-office-tubal-assessment

12/17/2025

“When state laws narrow the circumstances in which clinicians feel safe intervening, it can delay essential care, which directly conflicts with Americans’ right to timely emergency care.” — Liana Woskie, PhD, Tufts University

A new JAMA Health Forum study shows that restrictive abortion laws with no health exception are associated with a significant increase in EMTALA violations, particularly involving obstetric emergencies — despite federal law requiring emergency treatment.

📖 Read more: https://hubs.li/Q03Yx9p80

12/17/2025

Adjunct therapies may help reduce fever linked to epidural analgesia during labor.

A new network meta-analysis shows that magnetic bead auricular point therapy, electroacupuncture, and prophylactic steroids added to standard epidurals can significantly lower the risk of epidural-related maternal fever (ERMF).

These findings highlight opportunities to refine labor pain management and improve maternal outcomes.

📖 Read more: https://hubs.li/Q03Yww3h0

12/17/2025

Postpartum hemorrhage may be more common than previously thought.
A systematic review in The Lancet Obstetrics, Gynecology, & Women’s Health found that objective blood loss assessment (vs visual estimates) detects significantly more cases after childbirth — especially in vaginal births.

Better measurement can help improve care, resources, and outcomes for birthing people.

📖 Read more: https://hubs.li/Q03Ywj_Y0

A study found that objective blood loss assessment detects postpartum hemorrhage more frequently than subjective visual estimation.

12/16/2025

Acute heavy is linked to increased red blood cell transfusion use and higher treatment costs, according to a recent study.

Read more: https://www.contemporaryobgyn.net/view/high-costs-and-transfusions-linked-to-acute-heavy-menstrual-bleeding